Crinetics Reviews CRN04894 Single-Ascending Dose Results
August 10, 2021
Crinetics held a conference call and live audio webcast discussing the results of the CRN04894 single ascending dose cohorts from the first-in-human Phase 1 clinical study.
August 10, 2021
Crinetics held a conference call and live audio webcast discussing the results of the CRN04894 single ascending dose cohorts from the first-in-human Phase 1 clinical study.
"*" indicates required fields
"*" indicates required fields